GGrantIndex
← Leaderboards

Christy Russell

University Of Southern California

$719,837
Attributed
$719,837
Total exposure
5
Grants
0
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding mix

By agency

NIH$719,837 · 5

By mechanism

M01$719,837 · 5

Top collaborators

No co-investigators on record.

Most similar at University Of Southern California

Same institution · by research overlap

Others in their field

Top investigators on “Human Subject

Research focus

Human SubjectHuman Therapy EvaluationClinical ResearchNeoplasm /Cancer ChemotherapyCombination ChemotherapyBreast NeoplasmsPharmacokineticsCis Platinum CompoundFemaleDrug Screening /EvaluationImmunomodulatorsNeoplasm /Cancer Relapse /RecurrenceCytosine ArabinosideDrug ResistanceGemcitabinePaclitaxelGliomaHydroxyureaImmunocytochemistryOncogenesUridineClinical Trial Phase IDosageNucleoside Analog

Grant awards (17)

Gemcitabine and Cisplatin in Treatment of Breast Cancer$25,675
M01 · FY2004 · RR
SWOG 9149--CISPLATIN PRECEDED BY 12HR INFUSION OF HYDROXY &ARA C IN GLIOMA$0
M01 · FY2002 · RR
VX710 &TAXOL--EFFECT IN WOMEN W/ ADV BREAST CANCER REFRACTORY TO TAXOL$0
M01 · FY2002 · RR
VX710 &TAXOL--EFFECT IN WOMEN W/ ADV BREAST CANCER REFRACTORY TO TAXOL$155,764
M01 · FY2001 · RR
SWOG 9149--CISPLATIN PRECEDED BY 12HR INFUSION OF HYDROXY &ARA C IN GLIOMA$155,764
M01 · FY2001 · RR
SWOG 9149--CISPLATIN PRECEDED BY 12HR INFUSION OF HYDROXY &ARA C IN GLIOMA$0
M01 · FY2001 · RR
VX710 &TAXOL--EFFECT IN WOMEN W/ ADV BREAST CANCER REFRACTORY TO TAXOL$0
M01 · FY2001 · RR
SWOG 9149--CISPLATIN PRECEDED BY 12HR INFUSION OF HYDROXY &ARA C IN GLIOMA$155,764
M01 · FY2000 · RR
VX710 &TAXOL--EFFECT IN WOMEN W/ ADV BREAST CANCER REFRACTORY TO TAXOL$155,764
M01 · FY2000 · RR
VX710 &TAXOL--EFFECT IN WOMEN W/ ADV BREAST CANCER REFRACTORY TO TAXOL$35,553
M01 · FY2000 · RR
SWOG 9149--CISPLATIN PRECEDED BY 12HR INFUSION OF HYDROXY &ARA C IN GLIOMA$35,553
M01 · FY2000 · RR
TRIAL OF 5-FLUORO-2'-DEOXYCYTIDINE W TETRAHYDROURIDINE$0
M01 · FY2000 · RR
TRIAL OF 5-FLUORO-2'-DEOXYCYTIDINE W TETRAHYDROURIDINE$0
M01 · FY2000 · RR
GEMCITABINE AND CISPLATIN IN MINIMALLY PRETREATED BREAST CANCER$0
M01 · FY2000 · RR
GEMCITABINE AND CISPLATIN IN MINIMALLY PRETREATED BREAST CANCER$0
M01 · FY2000 · RR
GEMCITABINE AND CISPLATIN IN HEAVILY PRETREATED BREAST CANCER$0
M01 · FY2000 · RR
GEMCITABINE AND CISPLATIN IN HEAVILY PRETREATED BREAST CANCER$0
M01 · FY2000 · RR